| 1 |
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3) [J]. JAMA, 2016, 315(8): 801-810.
|
| 2 |
Hawiger J, Veach RA, Zienkiewicz J. New paradigms in sepsis: from prevention to protection of failing microcirculation [J]. J Thromb Haemost, 2015, 13(10): 1743-1756.
|
| 3 |
Sharawy N, Lehmann C. New directions for sepsis and septic shock research [J]. J Surg Res, 2015, 194(2): 520-527.
|
| 4 |
Romero-Bermejo FJ, Ruiz-Bailen M, Gil-Cebrian J, et al. Sepsis-induced cardiomyopathy [J]. Curr Cardiol Rev, 2011, 7(3): 163-183.
|
| 5 |
Sato R, Nasu M. A review of sepsis-induced cardiomyopathy [J]. J Intensive Care, 2015, 3: 48.
|
| 6 |
De Montmolin E, Aboab J, Mansart A, et al. Bench-to-bedside review: β-adrenergic modulation in sepsis [J]. Crit Care, 2009, 13(5): 1-8.
|
| 7 |
Zaky A, Deem S, Bendjelid K, et al. Characterization of cardiac dysfunction in sepsis: an ongoing challenge [J]. Shock, 2014, 41(1): 12-24.
|
| 8 |
Rudiger A. Beta-block the septic heart [J]. Crit Care Med, 2010, 38(10 Suppl): s608-612.
|
| 9 |
Kakihara Y, Ito T, Nakahara M, et al. Sepsis-induced myocardial dysfunction: pathophysiology and treatment [J]. J Intensive Care, 2016, 4: 22.
|
| 10 |
Sanfilippo F, Corredor C, Fletcher N, et al. Erratum to: diastolic dysfunction and mortality in septic patients: a systematic review and meta-analysis [J]. Intensive Care Med, 2015, 41(6): 1178-1179.
|
| 11 |
Huang SJ, Nalos M, Mclean AS. Is early ventricular dysfunction or dilatation associated with lower mortality rate in adult severe sepsis and septic shock? a meta-analysis [J]. Crit Care, 2013, 17(3): R96.
|
| 12 |
Suzuki T, Suzuki Y, Okuda J, et al. Sepsis-induced cardiac dysfunction and β-adrenergic blockade therapy for sepsis [J]. J Intensive Care, 2017, 5(1): 22.
|
| 13 |
Woo AY, Xiao RP. β-Adrenergic receptor subtype signaling in heart: from bench to bedside [J]. Acta Pharmacol Sin, 2012, 33(3): 335-341.
|
| 14 |
Brinks H, Koch WJ. BetaARKct: a therapeutic approach for improved adrenergic signaling and function in heart disease [J]. J Cardiovasc Transl Res, 2010, 3(5): 499-506.
|
| 15 |
杨承志，李子健. βarrestin与β肾上腺素受体 [J]. 中国细胞生物学学报, 2012, 34(11): 1080-1088.
|
| 16 |
Singh M, Moniri NH. Reactive oxygen species are required for β2 adrenergic receptor-β-arrestin interactions and signaling to ERK1/2 [J]. Biochem Pharmacol, 2012, 84(5): 661.
|
| 17 |
Lymperopoulos A, Rengo G, Koch WJ. GRK2 inhibition in heart failure: something old, something new [J]. Curr Pharm Des, 2012, 18(2): 186-191.
|
| 18 |
Brinks H, Boucher M, Gao E, et al. Level of G-protein-coupled receptor kinase-2 determines myocardial ischemia/reperfusion injury via pro- and anti-apoptotic mechanisms [J]. Circ Res, 2010, 107: 1140-1149.
|
| 19 |
Penela P, Murga C, Ribas C, et al. The complex G protein-coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets [J]. Br J Pharmacol, 2010, 160(4): 821-832.
|
| 20 |
Rengo G, Lymperopoulos A, Leosco D, et al. GRK2 as a novel gene therapy target in heart failure [J]. J Mol Cell Cardiol, 2011, 50(5): 785-792.
|
| 21 |
Völkers M, Weidenhammer C, Herzog N, et al. The inotropic peptide βARKct improves βAR responsiveness in normal and failing cardiomyocytes through G(βγ)-mediated L-type calcium current disinhibition [J]. Circ Res, 2011, 108(1): 27-39.
|
| 22 |
苗也，陈晖，李敏, 等. β肾上腺素受体激酶抑制剂对心肌梗死后心力衰竭大鼠β肾上腺素受体信号传导的影响 [J/CD]. 中华临床医师杂志(电子版), 2013, 7(24): 11441-11445.
|
| 23 |
马潇，陈晖，沈潞华. G蛋白偶联受体激酶2诱导心肌细胞肥大机制研究 [J]. 中国循环杂志, 2017, 32(S1): 20-21..
|
| 24 |
Schlegel P, Reinkober J, Meinhardt E, et al. G protein-coupled receptor kinase 2 promotes cardiac hypertrophy [J]. PLoS One, 2017, 12(7): e0182110.
|
| 25 |
Levin MC, Marullo S, Muntaner O, et al. The myocardium-protective Gly-49 variant of the beta 1-adrenergic receptor exhibits constitutive activity and increased desensitization and down-regulation [J]. J Biol Chem, 2002, 277(34): 30429-30435.
|
| 26 |
Li YJ, Li N, Yang L, et al. Polymorphisms of Arg389Gly of β1-adrenergic receptor gene and essential hypertension risk: a meta analysis [J]. Zhonghua Yi Xue Za Zhi, 2011, 91(44): 3115-3119.
|
| 27 |
Zhou Y, Song Y, Shaikh Z, et al. MicroRNA-155 attenuates late sepsis-induced cardiac dysfunction through JNK and β-arrestin 2 [J]. Oncotarget, 2017, 8(29): 47317-47329.
|